The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
The approval makes mFLUSIVA Moderna’s fourth FDA-cleared product and the first messenger RNA-based flu vaccine.
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season.
Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older. ・Capricor is seeking full approval for Deramiocel, a cell therapy aimed at heart ...